News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
372,360 Results
Type
Article (23092)
Company Profile (117)
Press Release (349151)
Multimedia
Podcasts (54)
Webinars (10)
Section
Business (114415)
Career Advice (959)
Deals (20526)
Drug Delivery (79)
Drug Development (50975)
Employer Resources (95)
FDA (8784)
Job Trends (8479)
News (198980)
Policy (18429)
Tag
Academia (1342)
Academic (1)
Accelerated approval (2)
Adcomms (9)
Allergies (57)
Alliances (30149)
ALS (61)
Alzheimer's disease (691)
Antibody-drug conjugate (ADC) (59)
Approvals (8806)
Artificial intelligence (153)
Autoimmune disease (13)
Automation (8)
Bankruptcy (181)
Best Places to Work (6342)
BIOSECURE Act (11)
Biosimilars (68)
Biotechnology (50)
Bladder cancer (35)
Brain cancer (17)
Breast cancer (138)
Cancer (1059)
Cardiovascular disease (119)
Career advice (817)
Career pathing (21)
CAR-T (63)
Cell therapy (177)
Cervical cancer (11)
Clinical research (42717)
Collaboration (458)
Compensation (183)
Complete response letters (17)
COVID-19 (1521)
CRISPR (28)
C-suite (151)
Cystic fibrosis (52)
Data (1237)
Denatured (19)
Depression (18)
Diabetes (153)
Diagnostics (2582)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (29)
Drug discovery (77)
Drug pricing (85)
Drug shortages (24)
Duchenne muscular dystrophy (56)
Earnings (41018)
Editorial (27)
Employer branding (8)
Employer resources (86)
Events (51775)
Executive appointments (506)
FDA (9480)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (372)
Gene editing (53)
Generative AI (12)
Gene therapy (160)
GLP-1 (501)
Government (2100)
Grass and pollen (4)
Guidances (88)
Healthcare (7904)
Huntington's disease (9)
IgA nephropathy (19)
Immunology and inflammation (65)
Indications (18)
Infectious disease (1590)
Inflammatory bowel disease (91)
Inflation Reduction Act (7)
Influenza (25)
Intellectual property (55)
Interviews (147)
IPO (8142)
IRA (35)
Job creations (2417)
Job search strategy (728)
Kidney cancer (7)
Labor market (20)
Layoffs (239)
Leadership (10)
Legal (4382)
Liver cancer (33)
Lung cancer (131)
Lymphoma (79)
Machine learning (6)
Management (34)
Manufacturing (206)
MASH (59)
Medical device (4050)
Medtech (4053)
Mergers & acquisitions (12692)
Metabolic disorders (425)
Multiple sclerosis (53)
NASH (19)
Neurodegenerative disease (42)
Neuropsychiatric disorders (10)
Neuroscience (1005)
NextGen: Class of 2025 (3115)
Non-profit (1985)
Now hiring (8)
Obesity (225)
Opinion (143)
Ovarian cancer (35)
Pain (74)
Pancreatic cancer (35)
Parkinson's disease (80)
Partnered (12)
Patents (142)
Patient recruitment (56)
Peanut (23)
People (37640)
Pharmaceutical (67)
Pharmacy benefit managers (15)
Phase I (11150)
Phase II (18459)
Phase III (16018)
Pipeline (743)
Policy (105)
Postmarket research (1819)
Preclinical (4464)
Press Release (48)
Prostate cancer (71)
Psychedelics (15)
Radiopharmaceuticals (149)
Rare diseases (238)
Real estate (3387)
Recruiting (34)
Regulatory (13155)
Reports (20)
Research institute (1278)
Resumes & cover letters (122)
Rett syndrome (1)
RNA editing (2)
RSV (23)
Schizophrenia (49)
Series A (72)
Series B (43)
Service/supplier (5)
Sickle cell disease (39)
Special edition (7)
Spinal muscular atrophy (106)
Sponsored (8)
Startups (2249)
State (2)
Stomach cancer (6)
Supply chain (39)
Tariffs (40)
The Weekly (33)
Vaccines (392)
Venture capitalists (19)
Weight loss (152)
Women's health (19)
Worklife (9)
Date
Today (59)
Last 7 days (461)
Last 30 days (1542)
Last 365 days (16324)
2025 (6003)
2024 (17701)
2023 (20086)
2022 (27229)
2021 (29116)
2020 (27975)
2019 (24072)
2018 (18624)
2017 (19169)
2016 (18476)
2015 (21948)
2014 (16756)
2013 (13795)
2012 (14959)
2011 (15667)
2010 (14041)
Location
Africa (459)
Alabama (19)
Alaska (4)
Arizona (85)
Arkansas (4)
Asia (26533)
Australia (4006)
California (2741)
Canada (1172)
China (329)
Colorado (110)
Connecticut (110)
Delaware (82)
Europe (57332)
Florida (478)
Georgia (104)
Idaho (23)
Illinois (300)
India (21)
Indiana (186)
Iowa (2)
Japan (126)
Kansas (66)
Kentucky (16)
Louisiana (8)
Maine (13)
Maryland (448)
Massachusetts (2162)
Michigan (61)
Minnesota (169)
Missouri (36)
Montana (11)
Nebraska (11)
Nevada (24)
New Hampshire (14)
New Jersey (1039)
New Mexico (14)
New York (893)
North Carolina (511)
North Dakota (2)
Northern California (1169)
Ohio (84)
Oklahoma (6)
Oregon (19)
Pennsylvania (692)
Puerto Rico (8)
Rhode Island (12)
South America (710)
South Carolina (11)
Southern California (1116)
Tennessee (47)
Texas (375)
United States (11149)
Utah (56)
Virginia (101)
Washington D.C. (36)
Washington State (259)
Wisconsin (28)
372,360 Results for "cspc pharmaceutical group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
For an exclusive license to the preclinical Lp(a) disruptor, AstraZeneca is paying CSPC Pharmaceutical Group $100 million upfront and offering up to $1.92 billion in regulatory and commercial milestones.
October 7, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Drug Development
Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023
Elevation Oncology, Inc. together with CSPC Pharmaceutical Group Limited, announced promising initial clinical data for SYSA1801 from the ongoing Phase 1 dose escalation and expansion study in China.
June 3, 2023
·
8 min read
Business
Elevation Oncology Expands Pipeline through Exclusive Licensing of EO-3021 (SYSA1801), a Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate, From CSPC Pharmaceutical Group
Elevation Oncology, Inc. today announced that it has entered into an exclusive license agreement with CSPC Megalith Biopharmaceutical Co., Ltd, a subsidiary of CSPC Pharmaceutical Group Limited (CSPC; HKEX: 01093) to develop and commercialize EO-3021.
July 28, 2022
·
9 min read
Press Releases
Stevanato Group to Participate in Upcoming Investor Conferences - May 9, 2025
May 12, 2025
·
1 min read
Press Releases
Orion Group Interim Report January–March 2025
April 23, 2025
·
6 min read
Press Releases
Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France
April 29, 2025
·
3 min read
Press Releases
Sunflower Therapeutics Announces an Exclusive Sales Representation Agreement with Optimal Biotech Group
April 30, 2025
·
3 min read
Press Releases
Devonian Health Group Reports Second Quarter 2025 Financial Results
April 15, 2025
·
6 min read
Press Releases
LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2024 RESULTS
May 2, 2025
·
11 min read
1 of 37,236
Next
